Global Roundtable Stock

Global Roundtable P/S

The (Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of Global Roundtable (GRCU) as of Aug 2, 2026 is 0.57.

P/S

0.57

Last updated:

As of Aug 2, 2026, Global Roundtable's P/S ratio stood at 0.57, a % change from the - P/S ratio recorded in the previous year.

The Global Roundtable P/S history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/S
Date
P/S
Jan 1, 2005
0.00 base
Jan 1, 2006
0.00 base
Jan 1, 2007
0.00 base
Jan 1, 2008
0.00 base
Jan 1, 2009
0.00 base
Jan 1, 2010
0.00 base
Jan 1, 2011
0.00 base
Jan 1, 2012
0.00 base
YEARP/S
2012 -
2011 -
2010 -
2009 -
2008 -
2007 -
2006 -
2005 -
2004 -
Access this data via the Eulerpool API

Global Roundtable Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Global Roundtable's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Global Roundtable's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Global Roundtable's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Global Roundtable grows earnings faster than its peers.

Global Roundtable Stock analysis

What does Global Roundtable do? Green Cures & Botanical Distribution Inc. was founded in 2014 in California, USA. The company is a provider of natural products, particularly CBD products. The main business of Green Cures & Botanical Distribution Inc. is the manufacturing and sale of CBD products. CBD, a natural component of hemp, is known for its health benefits and does not have the psychoactive effects of THC. The company offers a wide range of CBD products, including oils, capsules, tinctures, extracts, salves, balms, and more, in various strengths to meet the individual needs of customers. In addition, the company also offers other natural products such as hemp products and supplements. Green Cures & Botanical Distribution Inc. aims to produce high-quality natural products that support the well-being and health of customers. The company's business model includes participation in the hemp industry to foster growth and gain a competitive advantage. Green Cures & Botanical Distribution Inc. is divided into different sectors to cover various aspects of the business, including the production and sale of CBD products, offering hemp products, and focusing on supplements and natural products. Research and development are core competencies of the company, which strives to explore and develop innovative natural products that have the potential to improve customers' well-being and health. Green Cures & Botanical Distribution Inc. places a strong emphasis on quality and sustainability, using only natural ingredients sourced from organic farming and avoiding synthetic chemicals and pesticides. The company is also committed to environmental protection and social responsibility. Overall, Green Cures & Botanical Distribution Inc. is a leading provider of natural products, particularly CBD products, offering a wide range of options. Research and development, as well as quality and sustainability, are central to the company's business model. Global Roundtable is one of the most popular companies on Eulerpool.

P/S Details

Decoding Global Roundtable's P/S Ratio

Global Roundtable's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Global Roundtable's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Global Roundtable's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Global Roundtable’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Global Roundtable stock

(Price-Sales Ratio) is an important metric for stock valuation. It is calculated by dividing the current share price by the revenue per share. The P/S indicates how many years a company needs to generate the revenue per share as profit. A low P/S suggests that a stock may be undervalued, while a high P/S could indicate overvaluation. However, it is important to always consider the P/S in the context of the industry and the company. of Global Roundtable is 0.57 in 2026.

The P/S ratio when valuing a stock.

The price-to-sales ratio (P/S ratio) is an important tool of technical analysis that assists investors in evaluating stocks. It refers to the earnings per share of a company and its price movements. This indicator can be used to determine a stock's fair value, relative to the company's earnings.

History of the Price-to-Sales Ratio

The price-to-sales ratio is a relatively new indicator. It was first used in the 1980s by John Price when he developed the Price-to-Sales Index (PSI). Price wanted to find a way to value stocks taking into account their earnings. He noticed that many stock prices were not in line with their earnings situation. The PSI has since become an important analytical tool and is often referred to as the P/S ratio.

Calculation of the price-to-sales ratio

The price-to-sales ratio is easy to calculate. It is determined by dividing the current stock price by the company's earnings per share. P/S ratio = Stock price / Earnings per share. For example, if a company's stock price is $10 and the earnings per share is $2, then the P/S ratio is 5.

Application of the Price-to-Sales Ratio

The Price-to-Sales ratio is a useful tool for determining a fairly valued stock price. A low P/S ratio may indicate that a stock price is undervalued, which could be a good entry opportunity. However, a high Price-to-Sales ratio may indicate that a stock price is overvalued and investors should exercise caution.

An example: A company has a stock price of 20 USD and an earnings per share of 2 USD. The P/E ratio is 10. This could indicate that the stock price is overvalued and investors should be cautious before buying.

Investors and the price-to-sales ratio

Investors use the price-to-sales ratio to determine whether a company's stock price is fairly valued or not. They can compare the P/S ratio to see how the stock price relates to the company's earnings. Investors can also observe the P/S ratio over a longer period of time to see if the stock price changes in relation to the company's earnings.

Advantages and Disadvantages of the Price-to-Sales Ratio

The greatest advantage of the price-to-sales ratio is that it is a simple and understandable tool to determine the fair value of a stock price. It can also help investors identify stocks that are undervalued. One disadvantage is that the P/S ratio does not provide information about the company's profits. Therefore, investors should also consider other financial ratios before investing.

In today's time, the price-to-sales ratio is an important tool for investors to evaluate stocks and identify potential investment opportunities. It can help find a fairly valued stock price and identify stocks that are undervalued. However, investors should also consider other financial indicators before making an investment decision.

Access this data via the Eulerpool API

Valuation — Global Roundtable

All Key Metrics — Global Roundtable